Larimar Therapeutics

$20.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.31 (+6.68%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell LRMR and other stocks, options, and ETFs commission-free!

About LRMR

Larimar Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia. The company was founded on May 29, 2020 and is headquartered in Bala Cynwyd, PA. The listed name for LRMR is Larimar Therapeutics, Inc. Common Stock.

CEO
Carole S. Ben-Maimon
Employees
7
Headquarters
Bala Cynwyd, Pennsylvania
Founded
2020
Market Cap
321.10M
Price-Earnings Ratio
Dividend Yield
Average Volume
48.53K
High Today
$21.73
Low Today
$19.55
Open Price
$19.55
Volume
33.24K
52 Week High
$23.72
52 Week Low
$7.43

Collections

LRMR Earnings

-$1.21
-$0.81
-$0.40
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, Pre-Market

You May Also Like